A Practice-changing Culture Method Relying on Shaking Substantially Increases Mitochondrial Energy Metabolism and Functionality of Human Liver Cell Lines
Overview
Authors
Affiliations
Practice-changing culturing techniques of hepatocytes are highly required to increase their differentiation. Previously, we found that human liver cell lines HepaRG and C3A acquire higher functionality and increased mitochondrial biogenesis when cultured in the AMC-Bioartificial liver (BAL). Dynamic medium flow (DMF) is one of the major contributors to this stimulatory effect. Recently, we found that DMF-culturing by shaking of HepaRG monolayers resulted in higher mitochondrial biogenesis. Here we further investigated the effect of DMF-culturing on energy metabolism and hepatic functionality of HepaRG and C3A monolayers. HepaRG and C3A DMF-monolayers were incubated with orbital shaking at 60 rpm during the differentiation phase, while control monolayers were maintained statically. Subsequently, energy metabolism and hepatic functionality were compared between static and DMF-cultures. DMF-culturing of HepaRG cells substantially increased hepatic differentiation; transcript levels of hepatic structural genes and hepatic transcription regulators were increased up to 15-fold (Cytochrome P450 3A4) and nuclear translocation of hepatic transcription factor CEBPα was stimulated. Accordingly, hepatic functions were positively affected, including ammonia elimination, urea production, bile acid production, and CYP3A4 activity. DMF-culturing shifted energy metabolism from aerobic glycolysis towards oxidative phosphorylation, as indicated by a decline in lactate production and glucose consumption, and an increase in oxygen consumption. Similarly, DMF-culturing increased mitochondrial energy metabolism and hepatic functionality of C3A cells. In conclusion, simple shaking of monolayer cultures substantially improves mitochondrial energy metabolism and hepatic differentiation of human liver cell lines. This practice-changing culture method may prove to prolong the in-vitro maintenance of primary hepatocytes and increase hepatic differentiation of stem cells.
Li W, Li P, Li N, Du Y, Lu S, Elad D Am J Physiol Gastrointest Liver Physiol. 2020; 320(3):G272-G282.
PMID: 33296275 PMC: 8609567. DOI: 10.1152/ajpgi.00379.2019.
CYP3A5 suppresses metastasis of lung adenocarcinoma through ATOH8/Smad1 axis.
Mao Q, Wang L, Liang Y, Dong G, Xia W, Hu J Am J Cancer Res. 2020; 10(10):3194-3211.
PMID: 33163265 PMC: 7642649.
Adam A, Jongejan A, Moerland P, van der Mark V, Elferink R, Chamuleau R Cytotechnology. 2020; 72(3):377-395.
PMID: 32130581 PMC: 7225227. DOI: 10.1007/s10616-020-00384-w.
Large-Scale Production of LGR5-Positive Bipotential Human Liver Stem Cells.
Schneeberger K, Sanchez-Romero N, Ye S, van Steenbeek F, Oosterhoff L, Palacin I Hepatology. 2019; 72(1):257-270.
PMID: 31715015 PMC: 7496924. DOI: 10.1002/hep.31037.
End-stage liver failure: filling the treatment gap at the intensive care unit.
Chamuleau R, Hoekstra R J Artif Organs. 2019; 23(2):113-123.
PMID: 31535298 PMC: 7228976. DOI: 10.1007/s10047-019-01133-3.